The Center, Native Son, and Gilead present Black, Queer, & Here, a 2024 election forum on key issues facing the Black LGBTQ+ ...

Elgin's Landon Shepard recorded 15 tackles and three tackles for a loss. He also recovered a fumble that he forced in a ...

On Tuesday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $88.16 which represents a slight increase of $1.87 or 2.17% from the prior close of $86.29. The stock opened at ...

Yet another therapy with FDA accelerated approval suffers a setback; Sage’s tough year continues; Sanofi drops $326 million ...

Students at Park Avenue Elementary and Mount Gilead Middle School who won the essay and coloring contests were awarded ...

Book lovers from across the area convened on Cote Winery in Mount Gilead on Sept. 24 to celebrate the finale of the monthlong ...

Signaturefd LLC boosted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 12.1% in the third ...

Question: My problem is that some question certain character traits of President Trump and his fitness for office. I really don’t think sitting out this election is a proper option. I read your col ...

Gazette's Football Power Rankings, Ashland and Hillsdale both have impressive wins, while Black River makes a move.

Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Gilead Sciences (GILD – Research Report) and keeping the price ...

Morgan Stanley notes that Gilead (GILD) and Arcellx’s (ACLX) anito-cel, a BCMA-directed CAR-T therapy in development for relapsed / ...

Gilead has made the decision to withdraw the accelerated approval of Trodelvy (sacituzumab govitecan) for advanced urothelial cancer in the United States.